| Literature DB >> 34497031 |
Lynn Unruh1, Sara Allin2, Greg Marchildon3, Sara Burke4, Sarah Barry5, Rikke Siersbaek6, Steve Thomas7, Selina Rajan8, Andriy Koval9, Mathew Alexander10, Sherry Merkur11, Erin Webb12, Gemma A Williams13.
Abstract
This paper compares health policy responses to COVID-19 in Canada, Ireland, the United Kingdom and United States of America (US) from January to November 2020, with the aim of facilitating cross-country learning. Evidence is taken from the COVID-19 Health System Response Monitor, a joint initiative of the European Observatory on Health Systems and Policies, the WHO Regional Office for Europe, and the European Commission, which has documented country responses to COVID-19 using a structured template completed by country experts. We show all countries faced common challenges during the pandemic, including difficulties in scaling-up testing capacity, implementing timely and appropriate containment measures amid much uncertainty and overcoming shortages of health and social care workers, personal protective equipment and other medical technologies. Country responses to address these issues were similar in many ways, but dissimilar in others, reflecting differences in health system organization and financing, political leadership and governance structures. In the US, lack of universal health coverage have created barriers to accessing care, while political pushback against scientific leadership has likely undermined the crisis response. Our findings highlight the importance of consistent messaging and alignment between health experts and political leadership to increase the level of compliance with public health measures, alongside the need to invest in health infrastructure and training and retaining an adequate domestic health workforce. Building on innovations in care delivery seen during the pandemic, including increased use of digital technology, can also help inform development of more resilient health systems longer-term.Entities:
Keywords: COVID-19; Europe; Government; North America; Public health; Workforce
Mesh:
Year: 2021 PMID: 34497031 PMCID: PMC9187506 DOI: 10.1016/j.healthpol.2021.06.012
Source DB: PubMed Journal: Health Policy ISSN: 0168-8510 Impact factor: 3.255
Selected indicators of population, health system resources and health status, 2018 or latest available year.
| Population (thousands)* | Population density (people per sq. km)** | Total Health expenditure (THE) as % of GDP | Government spending as % of THE | Physicians per 1000 population | Nurses per 1000 population | Curative care beds per 1000 population | Life expect-ancy, Total population at birth, Years | Mortality from prevent-able causes (Deaths per 100,000 population) | Mortality from treatable causes (Deaths per 100,000 population) | |
|---|---|---|---|---|---|---|---|---|---|---|
| CANADA | 36,027 | 4 | 10.8 | 70.4 | 2.74 | 10.87 | 3.0 | 82.0 | 114 | 56 |
| IRELAND | 4,652 | 71 | 6.8*** | 74.3 | 3.34 | 12.88 | 2.5 | 82.3 | 106 | 65 |
| UK | 65,860 | 275 | 10.3 | 77.8 | 3.91 | - | 2.5 | 81.3 | 118 | 69 |
| USA | 320,878 | 36 | 17.0 | 84.8 | 3.49 | 11.89 | 2.9 | 78.7 | 174 | 88 |
| OECD AVERAGE | - | - | 8.8 | 79.2 | 3.50 | 8.80 | 4.5 | 80.7 | 161 | 93 |
Fig. 1Confirmed COVID-19 cases and deaths in Canada, Ireland, the UK and the US. Note: Note: Direct comparison between countries should be treated with caution as each country has different testing capacity, availability and criteria, may measure and report confirmed cases and deaths differently, and reliability of data may also vary.
Preventing transmission: physical distancing measures and lockdowns.
| First Case | National State of Emergency | Travel restrictions | Lockdowns or stay at home orders | Lifting of first lock-down measures | Re-opening approach | School closings and reopening | Physical distancing & mask mandates | |
|---|---|---|---|---|---|---|---|---|
| CANADA | Jan 25 | On a regional (PT) basis March 13 -27 | March 18 | No compulsory lockdowns; voluntary stay at home advice issued, prohibitions on public and private gatherings varied by PT | Mid-May | Phased, varied by PT | Early spring 2020, fully reopened September, with timing varying by PT | Varied by PT/municipality |
| IRELAND | Feb 29 | No | Advisory | National mandate, end of March | May 29 | Phased, national until August when took regional approach | Spring 2020, fully reopened September | National mandate |
| UK | Jan 29 | No | Advisory quarantine | National mandate, end of March | Mid-May | Phased, varied by country | Spring 2020, fully reopened Septem-ber | Varied by country |
| US | Jan 20 | March 13 | 1/31- China; March– Europe & Canada | National voluntary, March 16; Some mandates in state/local areas | Some states late April, early May, most states mid-May | Phased, varied by state/ | Spring 2020, reopened to various degrees late August- early September | Varied by state/ local |
Fig. 2Google Community Mobility Trends: Visits to retail and recreation venues and public transport stations in North Atlantic Countries February –November 2020. Notes: Change in visitor numbers is measured relative to a baseline day; a baseline day is the median value from the 5-week period between Jan 3rd and Feb 6th 2020. This index is smoothed to the rolling 7-day average. Source: Ritchie [35], Google COVID-19 Community Mobility Trends (2020).
Preventing transmission: testing.
| Initial focus on priority populations* | Uniform testing strategy | Shortages of supplies | Referrals needed? | Locations | Test reporting time | Daily COVID-19 tests per thousand people in March/April (7-day smoothed)* | Daily COVID-19 tests per thousand people in October (7-day smoothed)* | Absolute (and relative) change in daily testing between March/April and October | |
|---|---|---|---|---|---|---|---|---|---|
| Yes | Varies by PT | Yes | Varies by PT | EDs, mobile units, drive throughs | Varies across and within PTs (e.g. from 2.75 to 5.75 days by region | 0.16 (March 18) | 1.84 in 10/16 | +1.68 (+1,043%) | |
| Yes | Yes | Not after initial period | Every-where provider referral required | Hospitals, GP offices, testing centers | 2-3 days, not always achieved | 0.32 (March 25) | 2.90 in 10/16 | +2.58 (+ 820%) | |
| Yes | Some variability in devolved countries | Not after initial period | Every-where: anyone sympto-matic can get a test | Test centers, mobile units, home tests | 59-61 hrs, not always achieved | 0.26 (April 7) | 3.85 in 10/16 | +3.59 (+1,365%) | |
| Yes | Varies by state/local | Yes | Varies by state/local | Physician offices, urgent care, testing centers, drive-thru | 3-4 days (5 -7 in some areas) | <0.01 (March 8) | 3.18 in 10/16 | +3.18 (+105,867%) |
Notes: *symptomatic individuals, travelers returning from high incidence areas, and/or high risk groups; * Source: [20].
COVID-19 response leadership.
| Pandemic plans | National public health response coordination | Regional public health responsibilities | Independence of public health agencies. | Independence of scientific advisory groups | |
|---|---|---|---|---|---|
| Yes | Centre for Emergency Preparedness and Response, a division of the Public Health Agency of Canada (PHAC). Multiple committees work to coordinate responses across the country. | PT ministries of health and public health agencies | PHAC is an agency of the federal government. PT public health agencies are part of government public health systems, with some PT “arm's length” agencies (e.g., Public Health Ontario and British Columbia Centre for Disease Control). | Many federal and PT scientific advisory groups with varying levels of transparency. The federal Minister of Health oversees PHAC; president and Chief Public Health Officer appointed by Prime Minister. | |
| Yes | Department of Health hosts National Public Health Emergency Team (NPHET) and HSE. New inter-mediary structure in Sept with secretary generals from government departments. | Regional public health departments | Part of government, but NPHET is reasonably independent. No undue influence by government on agency. | Coronavirus Expert Advisory Group advises NPHET; is independent of government | |
| Yes | Department of Health and Social Care (DHSC) | Public health departments in each nation | PHE is an executive agency of the DHSC and accountable to UK government; public health departments in devolved nations accountable to governments. | Scientific Advisory Group for Emergencies (SAGE), New & Emerging Repiratory Virus Threats Advisory Group, Advisory Committee on Dangerous Pathogens, and others. Some questions regarding independence as some SAGE members are government employees while meetings attended by government advisors | |
| Yes, not activated | Centers for Disease Control and Prevention (CDC) + Corona-virus Task Force | State, county, and city public health departments | CDC part of US Department of Health and Human Service (HHS); issues with gov. interference in public health decisions & guidelines | Dr's Fauci and Brix on the Corona virus Task Force, CDC, National Institutes of Health. These were marginalized over time, scientific evidence ignored & contradicted by gov. |